Geode Capital Management
MNPR icon

Geode Capital Management’s Monopar Therapeutics MNPR Stock Holding History

Geode Capital Management’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
112,578
+12,660
+13% +$784K ﹤0.01% 2515
2026
Q1 		$5.48M Buy
99,918
+911
+0.9% +$55K ﹤0.01% 2692
2025
Q4 		$6.47M Buy
99,007
+14,046
+17% +$1.15M ﹤0.01% 2630
2025
Q3 		$6.94M Sell
84,961
-11,958
-12% -$535K ﹤0.01% 2618
2025
Q2 		$3.47M Buy
96,919
+48,379
+100% +$1.76M ﹤0.01% 2914
2025
Q1 		$1.77M Buy
48,540
+9,944
+26% +$358K ﹤0.01% 3086
2024
Q4 		$849K Buy
38,596
+24,530
+174% +$412K ﹤0.01% 3426
2024
Q3 		$94.8K Buy
14,066
+2,059
+17% +$6.89K ﹤0.01% 4118
2024
Q2 		$44.9K Buy
12,007
+3,767
+46% +$13.3K ﹤0.01% 4303
2024
Q1 		$28.1K Hold
8,240
– – ﹤0.01% 4430
2023
Q4 		$14K Hold
8,240
– – ﹤0.01% 4561
2023
Q3 		$23.5K Sell
8,240
-138
-2% -$482 ﹤0.01% 4589
2023
Q2 		$35.8K Hold
8,378
– – ﹤0.01% 4575
2023
Q1 		$59.5K Hold
8,378
– – ﹤0.01% 4477
2022
Q4 		$99K Buy
8,378
+544
+7% +$6.64K ﹤0.01% 4407
2022
Q3 		$59K Hold
7,834
– – ﹤0.01% 4730
2022
Q2 		$85K Hold
7,834
– – ﹤0.01% 4645
2022
Q1 		$100K Hold
7,834
– – ﹤0.01% 4662
2021
Q4 		$126K Hold
7,834
– – ﹤0.01% 4650
2021
Q3 		$189K Buy
7,834
+2,082
+36% +$53.9K ﹤0.01% 4475
2021
Q2 		$169K Buy
5,752
+473
+9% +$13.5K ﹤0.01% 4399
2021
Q1 		$163K Buy
+5,279
New +$193K ﹤0.01% 4176

Other funds holding MNPR

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management's MNPR Position: Q2 2026 in Review

Geode Capital Management increased its Monopar Therapeutics (MNPR) stake by 13% in Q2 2026, buying an estimated $784K and bringing the position to 112,578 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Geode Capital Management first reported a position in MNPR in Q1 2021 and has held it in 22 quarters since. 96 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Geode Capital Management held 112,578 shares of Monopar Therapeutics worth $10.4M as of Q2 2026.
  • Geode Capital Management bought 12,660 Monopar Therapeutics shares in Q2 2026, an estimated $784K.
  • Monopar Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2515 holding.
  • Geode Capital Management first reported a position in Monopar Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • 96 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.